Please assess the completion status of the following clinical trial:

Trial Title: Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 3 months old living in the aera for the next 2 years, exlusive use of the study health facilities~Exclusion Criteria:~* Known chronic illness, e.g. TB, diabetes, renal failure severe malnutrition (weight-for-age (WAZ) \< 60% percentile) severe anaemia (Hb \< 5 g/dl), or permanent disability, that prevents or impedes study participation

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 4 Months
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): 1 day Sulfadoxine/Pyrimethamine + 3 days Amodiaquine
- 2 (Type: ACTIVE_COMPARATOR): 1 day of Sulfadoxine/Pyrimthamine and 3 days of Artesunate
- 3 (Type: PLACEBO_COMPARATOR): children of this gorup will receive only placebo dugs

Based on this trial design, predict the completion outcome and termination type (if applicable).